CytoMed Therapeutics Limited (GDTC)
NASDAQ: GDTC · Real-Time Price · USD
1.390
+0.030 (2.21%)
At close: Jan 6, 2026, 4:00 PM EST
1.380
-0.010 (-0.72%)
After-hours: Jan 6, 2026, 5:42 PM EST
CytoMed Therapeutics Market Cap
CytoMed Therapeutics has a market cap or net worth of $16.04 million as of January 6, 2026. Its market cap has decreased by -47.55% in one year.
Market Cap
16.04M
Enterprise Value
14.18M
1-Year Change
-47.55%
Ranking
Category
Stock Price
$1.39
Market Cap Chart
Since the IPO on April 14, 2023, CytoMed Therapeutics's market cap has decreased from $46.12M to $16.04M, a decrease of -65.22%. That is a compound annual growth rate of -32.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 5, 2026 | 15.69M | 1.87% |
| Dec 31, 2025 | 15.41M | -60.74% |
| Dec 31, 2024 | 39.24M | -30.55% |
| Dec 29, 2023 | 56.49M | 22.50% |
| Apr 14, 2023 | 46.12M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 932.96B |
| Johnson & Johnson | 490.58B |
| AbbVie | 388.17B |
| UnitedHealth Group | 311.48B |
| AstraZeneca | 280.48B |
| Novartis AG | 266.00B |
| Merck & Co. | 265.06B |
| Novo Nordisk | 241.55B |